Stephen P. Harrington
Presidente presso SPH Investments, Inc.
Posizioni attive di Stephen P. Harrington
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| SPH Investments, Inc. | Presidente | 01/01/1992 | - |
| SPH Equities, Inc. | Presidente | 15/10/2010 | - |
Storia della carriera di Stephen P. Harrington
Precedenti posizioni note di Stephen P. Harrington
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Zone Mining Ltd.
 Zone Mining Ltd. Other Metals/MineralsNon-Energy Minerals Zone Mining Ltd. engaged in precious metals and jewels mining industry. The company was founded on January 31, 2005 and was headquartered in Bala Cynwyd, PA. | Presidente | 01/01/2007 | 01/01/2007 |
| Direttore Finanziario/CFO | 01/01/2007 | 01/01/2007 | |
| Presidente | - | 01/01/2007 | |
| Segretario Aziendale | 01/01/2007 | 01/01/2007 | |
| Treasurer | 01/01/2007 | 01/01/2007 | |
| Touchstone Resources USA, Inc. | Presidente | 01/08/2005 | 01/08/2005 |
| Presidente | - | 01/08/2005 | |
| Segretario Aziendale | 01/08/2005 | 01/08/2005 | |
| Treasurer | 01/08/2005 | 01/08/2005 | |
| ENDEAVOUR INTERNATIONAL CORPORATION | Amministratore Delegato | 01/10/2001 | 01/02/2004 |
| Presidente | 01/10/2001 | 01/02/2004 | |
| RADIANT LOGISTICS, INC. | Direttore/Membro del Consiglio | 26/10/2007 | - |
| Independent Dir/Board Member | 26/10/2007 | - | |
Astralis Ltd.
 Astralis Ltd. BiotechnologyHealth Technology Astralis Ltd. research and develop drugs for the treatment of immune system disorders and skin diseases. The company's initial product is Psoraxine, a protein extract used for the treatment of the skin disease psoriasis. Psoraxine is a synthesized immuno-therapeutic agent, presented in liquid form and is packed in 0.5 mg ampules for intra-muscular injection. The company's second product is for the treatment of leishmaniasis. The company was founded on June 30, 2001 and is headquartered in Fairfield, NJ. | Direttore/Membro del Consiglio | - | - |
iCarbon Corp.
 iCarbon Corp. Other Metals/MineralsNon-Energy Minerals iCarbon Corp. mines and manufactures natural and synthetic graphite and carbon-based materials. The private company is based in Delano, PA and has subsidiaries in Canada, United States, and China. James E. Olive has been the CEO of the company since 2006. | Direttore/Membro del Consiglio | - | - |
Formazione di Stephen P. Harrington
| Yale University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 10 |
Posizioni
| President | 4 |
| Chairman | 3 |
| Director/Board Member | 3 |
Settori
| Non-Energy Minerals | 3 |
| Energy Minerals | 3 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| RADIANT LOGISTICS, INC. | Transportation |
| Aziende private | 7 |
|---|---|
Zone Mining Ltd.
Zone Mining Ltd. Other Metals/MineralsNon-Energy Minerals Zone Mining Ltd. engaged in precious metals and jewels mining industry. The company was founded on January 31, 2005 and was headquartered in Bala Cynwyd, PA. | Non-Energy Minerals |
| Touchstone Resources USA, Inc. | Energy Minerals |
Endeavour International Corp.
 Endeavour International Corp. Oil & Gas ProductionEnergy Minerals Endeavour International Corp. was engaged in exploration and development of oil and gas reserves. The company was founded by William L. Transier and John N. Seitz and was headquartered in Houston, TX. | Energy Minerals |
| SPH Investments, Inc. | |
| SPH Equities, Inc. | |
iCarbon Corp.
iCarbon Corp. Other Metals/MineralsNon-Energy Minerals iCarbon Corp. mines and manufactures natural and synthetic graphite and carbon-based materials. The private company is based in Delano, PA and has subsidiaries in Canada, United States, and China. James E. Olive has been the CEO of the company since 2006. | Non-Energy Minerals |
Astralis Ltd.
Astralis Ltd. BiotechnologyHealth Technology Astralis Ltd. research and develop drugs for the treatment of immune system disorders and skin diseases. The company's initial product is Psoraxine, a protein extract used for the treatment of the skin disease psoriasis. Psoraxine is a synthesized immuno-therapeutic agent, presented in liquid form and is packed in 0.5 mg ampules for intra-muscular injection. The company's second product is for the treatment of leishmaniasis. The company was founded on June 30, 2001 and is headquartered in Fairfield, NJ. | Health Technology |
